U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

BENZIMIDAZOLE

MORE DETAILS

E24GX49LD8

Status:
Possibly Marketed Outside US
Source:
NCT04326868: Phase 4 Interventional Completed Helminths Infection
(2019)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT04326868
First approved in 2011
Source:
21 CFR 352
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb08e241-439f-4b07-9f67-5d5dab3e5b75
Class (Stereo):
CHEMICAL (ACHIRAL)
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966